Skip to content
Riskpilot
← Back to search
Sign in
Get full access
IKAST FYSIOTERAPI III ApS
APS
Active
Advertising protection
CVR 36477539
Ellehammervej 4, 7430
Ikast
Physiotherapy activities
·
NACE 8695
Est. 2014 · 11 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Physiotherapy activities
/
IKAST FYSIOTERAPI III ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
—
—
—
—
-13
Staff expenses
-0
-0
-0
-0
-0
EBITDA
307
371
100
429
-13
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
307
371
100
429
-13
Net financials
318
384
127
442
1.044
Profit before tax
306
371
106
429
1.031
Tax
67
82
23
75
223
Net profit
238
289
82
354
808
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
922
818
343
772
1.721
Equity
826
715
298
652
1.460
Long-term debt
0
0
0
0
0
Short-term debt
85
102
6
88
226
Total debt
85
102
6
88
226
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1261700.0%
This company
2021
2025
Equity ratio
84.8%
This company
38.2%
Market median
+122% vs market
2021
2025
Return on equity
55.4%
This company
18.4%
Market median
+201% vs market
2021
2025
Net profit margin (of gross profit)
80849100.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.01×
This company
2021
2025
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on IKAST FYSIOTERAPI III ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
